Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Influenza's signature move

David F Tough¹

¹Epigenetics Discovery Performance Unit, Oncology and Immunoinflammation Therapy Area Units, GSK Medicines Research Centre, Stevenage, UK. david.f.tough@gsk.com.

Nature Immunology

|May 20, 2018

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Discovery of an Orally Available Potent ER Aminopeptidase 1 (ERAP1) Inhibitor That Enhances Antitumor Responses and Limits Inflammatory Autoimmunity <i>In Vivo</i>.

Journal of medicinal chemistry·2026

Same author

CBP/P300 Inhibition Impairs CD4+ T Cell Activation: Implications for Autoimmune Disorders.

Biomedicines·2024

Same author

The Epigenetic Reader Protein SP140 Regulates Dendritic Cell Activation, Maturation and Tolerogenic Potential.

Current issues in molecular biology·2023

Same author

Therapeutic opportunities for regulatory T-cell enhancing approaches.

Clinical and experimental immunology·2023

Same author

Modulation of macrophage inflammatory function through selective inhibition of the epigenetic reader protein SP140.

BMC biology·2022

Same author

Phase 1 and preclinical profiling of ESM-HDAC391, a myeloid-targeted histone deacetylase inhibitor, shows enhanced pharmacology and monocytopaenia.

British journal of clinical pharmacology·2022